Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TheraCRAB: Therapeutic Strategies for Carbapenem-Resistant Acinetobacter Baumannii Infections
NCT06440304Phase 4Recruiting
- Sponsor
- Clinical Hospital Center Zagreb
- Start
- Jan 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fosfomycin, eravacycline in Acinetobacter baumannii infection, Bacterial sepsis, sponsored by Clinical Hospital Center Zagreb. Started Jan 2025; status: recruiting.
02
Drugs
fosfomycineravacycline
03
Conditions
Acinetobacter baumannii infectionBacterial sepsis
Beyond the preview
Go deeper on NCT06440304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06440304.